Results 21 to 30 of about 99,604 (214)
El Contrato Social toca fondo ¿Qué sigue?
Revista Kavilando, 2023 Centro y Sur América, allí Colombia, tienen una condición especial en un escenario de crisis global, la primera es que posee los recursos naturales que requiere el mundo para paliar la crisis y la segunda, es que intenta consolidarse una nueva ola ...Alfonso Insuasty Rodríguez, Eulalia Borja Bedoya, Yani Vallejo Duque, Luis Alfredo Burbano Narváez, Santiago Salinas Miranda, Brenda Milena Perdomo Rodríguez, David Felipe Céspedes Rodríguez, Mateo Córdoba, Freddy Díaz, Cristóbal Silva González, Héctor Bello +10 moredoaj +1 more sourcePrevalence of overweight, obesity and central obesity and factors associated with BMI in indigenous yaqui people: a probabilistic cross-sectional survey
BMC Public Health, 2022 Background The Yaquis are an Indigenous group who inhabit in the state of Sonora in northwestern Mexico. This group has experienced changes in their lifestyle, moving from a traditional lifestyle to a more modern one, resulting in an increase of obesity ...Araceli Serna-Gutiérrez, Alejandro Arturo Castro-Juarez, Martín Romero-Martínez, Heliodoro Alemán-Mateo, Rolando Giovanni Díaz-Zavala, Luis Quihui-Cota, Gerardo Álvarez-Hernández, Ana Cristina Gallegos-Aguilar, Julián Esparza-Romero +8 moredoaj +1 more sourceStrategies to reengage patients lost to follow up in HIV care in high income countries, a scoping review
BMC Public Health, 2021 Despite remarkable achievements in antiretroviral therapy (ART), losses to follow-up (LTFU) might prevent the long-term success of HIV treatment and might delay the achievement of the 90–90-90 objectives.Jorge Palacio-Vieira, J. Reyes-Urueña, A. Imaz, A. Bruguera, L. Force, A. O. Llaveria, J. M. Llibre, I. Vilaró, Francesc Homar Borràs, V. Falcó, M. Riera, P. Domingo, E. de Lazzari, J. Miró, J. Casabona, Jordi Jose M. Juliana Andreu Sergio Yesika Jordi Esteve Casabona Miró Reyes Bruguera Moreno Diaz Aceiton M, J. Casabona, J. Miró, J. Reyes, A. Bruguera, S. Moreno, Y. Díaz, Jordi Aceitón, E. Muntada, J. Casabona, J. Miró, J. Reyes, E. Muntada, A. Bruguera, D. Podzamczer, A. Imaz, P. Domingo, J. M. Llibre, G. Navarro, C. Cortés, J. Mallolas, C. Manzardo, J. Tiraboschi, A. Curran, J. Burgos, M. Gracia Mateo, M. Gutierrez, J. Murillas, F. Segura, F. Homar, M. García-Gasalla, E. González, F. Vidal, J. Peraire, L. Force, E. León, À. Masabeu, I. Vilaró, A. Ortí, D. Dalmau, A. Jaén, A. Almuedo, E. de Lazzari, D. Giralt, B. Raventós, F. Gargoulas, T. Vanrell, J. Rubia, J. Vila, M. Ferres, B. Morell, M. Tamayo, J. Ambrosioni, M. Laguno, M. Martínez, J. Blanco, F. García Alcaide, E. Martínez, A. Jou, B. Clotet, M. Saumoy, A. Silva, P. Prieto, J. Navarro, E. Ribera, M. Gurguí, M. Ribas, A. Campins, F. Fanjul, M. Leyes, M. Peñaranda, L. Martin, H. Vilchez, S. Calzado, M. Cervantes, M. Amengual, M. Navarro, T. Payeras, C. Cifuentes, N. Abdulghani, T. Comella, M. Vargas, C. Viladés, P. Barrufet, I. Chivite, E. Chamarro, C. Escrig, M. Cairó, X. Martínez-Lacasa, R. Font, S. Meyer, Juanse Hernández +106 moresemanticscholar +1 more sourcePersonally Tailored Survival Prediction of Patients With Follicular Lymphoma Using Machine Learning Transcriptome-Based Models
Frontiers in Oncology, 2022 Follicular Lymphoma (FL) has a 10-year mortality rate of 20%, and this is mostly related to lymphoma progression and transformation to higher grades. In the era of personalized medicine it has become increasingly important to provide patients with an ...Adrián Mosquera Orgueira, Adrián Mosquera Orgueira, Adrián Mosquera Orgueira, Miguel Cid López, Miguel Cid López, Miguel Cid López, Andrés Peleteiro Raíndo, Andrés Peleteiro Raíndo, Andrés Peleteiro Raíndo, Aitor Abuín Blanco, Aitor Abuín Blanco, Jose Ángel Díaz Arias, Jose Ángel Díaz Arias, Marta Sonia González Pérez, Marta Sonia González Pérez, Beatriz Antelo Rodríguez, Beatriz Antelo Rodríguez, Beatriz Antelo Rodríguez, Laura Bao Pérez, Laura Bao Pérez, Laura Bao Pérez, Roi Ferreiro Ferro, Roi Ferreiro Ferro, Carlos Aliste Santos, Manuel Mateo Pérez Encinas, Manuel Mateo Pérez Encinas, Manuel Mateo Pérez Encinas, Máximo Francisco Fraga Rodríguez, Máximo Francisco Fraga Rodríguez, Máximo Francisco Fraga Rodríguez, Claudio Cerchione, Pablo Mozas, José Luis Bello López, José Luis Bello López, José Luis Bello López +34 moredoaj +1 more sourcePrognostic Stratification of Diffuse Large B-cell Lymphoma Using Clinico-genomic Models: Validation and Improvement of the LymForest-25 Model
HemaSphere, 2022 Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma. Despite notable therapeutic advances in the last decades, 30%–40% of affected patients develop relapsed or refractory disease that frequently precludes an infamous ...Adrián Mosquera Orgueira, Jose Ángel Díaz Arías, Miguel Cid López, Andrés Peleteiro Raíndo, Alberto López García, Rosanna Abal García, Marta Sonia González Pérez, Beatriz Antelo Rodríguez, Carlos Aliste Santos, Manuel Mateo Pérez Encinas, Máximo Francisco Fraga Rodríguez, José Luis Bello López +11 moredoaj +1 more sourceZearalenone Does Not Show Genotoxic Effects in the Drosophila melanogaster Wing Spot Test, but It Induces Oxidative Imbalance, Development, and Fecundity Alterations
Toxins, 2023 Zearalenone (ZEN) is a non-steroidal mycoestrogen produced by the Fusarium genus. ZEN and its metabolites compete with 17-beta estradiol for cytosolic estrogen receptors, causing reproductive alterations in vertebrates.Luis Felipe Santos-Cruz, Alberto Ponciano-Gómez, Juan Tomás Torres-Gregorio, Bertha Guadalupe Ramírez-Cruz, Gerardo Vázquez-Gómez, Luis Barbo Hernández-Portilla, Cesar Mateo Flores-Ortiz, Irma Elena Dueñas-García, María Eugenia Heres-Pulido, Laura Castañeda-Partida, Ángel Durán-Díaz, Myriam Campos-Aguilar, Santiago Cristobal Sigrist-Flores, Elías Piedra-Ibarra +13 moredoaj +1 more sourceComparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis & Rheumatology, 2019 To compare the efficacy of infliximab (IFX) versus adalimumab (ADA) as a first‐line biologic drug over 1 year of treatment in a large series of patients with refractory uveitis due to Behçet's disease (BD).B. Atienza-Mateo, J. Martín-Varillas, V. Calvo-Río, R. Demetrio-Pablo, E. Beltrán, J. Sánchez-Bursón, M. Mesquida, A. Adán, M. Hernández, M. Hernández-Garfella, E. Valls-Pascual, L. Martínez-Costa, A. Sellas-Fernández, M. Cordero‐Coma, M. Díaz‐Llopis, R. Gallego, J. L. García-Serrano, N. Ortego-Centeno, J. Herreras, A. Fonollosa, Á. García-Aparicio, O. Maíz-Alonso, A. Blanco, I. Torre-Salaberri, C. Fernández-Espartero, V. Jovaní, D. Peiteado, E. Pato, J. Cruz, C. Fernández-Cid, E. Aurrecoechea, M. García-Arias, S. Castañeda, M. A. Caracuel-Ruiz, C. Montilla-Morales, A. Atanes-Sandoval, F. Francisco, S. Insúa, S. González-Suárez, A. Sánchez-Andrade, F. Gamero, L. F. Linares Ferrando, F. Romero-Bueno, A. J. García-González, Raquel Almodóvar González, E. M. Muro, C. Carrasco-Cubero, A. Olivé, Á. Prior, J. Vázquez, Ó. Ruiz-Moreno, Fernando Jiménez-Zorzo, J. Manero, S. Muñoz Fernández, C. Fernández-Carballido, E. Rubio-Romero, F. Pages, F. Toyos-Sáenz de Miera, Myriam Gandía Martinez, D. Díaz-Valle, F. J. Lopez Longo, J. Nolla, E. Álvarez, Marcelino Martínez, J. González-López, P. Rodríguez-Cundín, J. Hernández, M. González-Gay, R. Blanco +68 moresemanticscholar +1 more sourceMachine Learning Improves Risk Stratification in Myelodysplastic Neoplasms: An Analysis of the Spanish Group of Myelodysplastic Syndromes
HemaSphere, 2023 Myelodysplastic neoplasms (MDS) are a heterogeneous group of hematological stem cell disorders characterized by dysplasia, cytopenias, and increased risk of acute leukemia.Adrian Mosquera Orgueira, Manuel Mateo Perez Encinas, Nicolas A Diaz Varela, Elvira Mora, Marina Díaz-Beyá, María Julia Montoro, Helena Pomares, Fernando Ramos, Mar Tormo, Andres Jerez, Josep F Nomdedeu, Carlos De Miguel Sanchez, Arenillas Leonor, Paula Cárcel, Maria Teresa Cedena Romero, Blanca Xicoy, Eugenia Rivero, Rafael Andres del Orbe Barreto, Maria Diez-Campelo, Luis E. Benlloch, Davide Crucitti, David Valcárcel +21 moredoaj +1 more source
